Health In Tech (NASDAQ:HIT - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating in a research note issued on Saturday.
Separately, Maxim Group raised shares of Health In Tech to a "strong-buy" rating and set a $2.50 price objective for the company in a research report on Thursday, June 26th.
View Our Latest Report on Health In Tech
Health In Tech Stock Up 7.4%
Shares of NASDAQ HIT traded up $0.17 during mid-day trading on Friday, hitting $2.48. The company's stock had a trading volume of 674,038 shares, compared to its average volume of 1,312,757. The company's fifty day simple moving average is $1.14 and its 200-day simple moving average is $2.14. Health In Tech has a one year low of $0.51 and a one year high of $7.59.
Health In Tech (NASDAQ:HIT - Get Free Report) last announced its quarterly earnings results on Monday, July 21st. The company reported $0.01 earnings per share for the quarter, meeting analysts' consensus estimates of $0.01. The company had revenue of $9.31 million during the quarter, compared to the consensus estimate of $7.96 million.
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the business. Cubist Systematic Strategies LLC acquired a new position in Health In Tech during the first quarter worth about $41,000. Arete Wealth Advisors LLC acquired a new position in Health In Tech during the first quarter worth about $47,000. Jane Street Group LLC acquired a new position in Health In Tech during the first quarter worth about $48,000. Finally, XTX Topco Ltd acquired a new position in Health In Tech during the first quarter worth about $59,000.
Health In Tech Company Profile
(
Get Free Report)
Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.
Featured Articles
Before you consider Health In Tech, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Health In Tech wasn't on the list.
While Health In Tech currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.